Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when reasoning about how an ACL paper travels through ACL Rolling Review and conference commitment, covering reviewer and area-chair roles, meta-reviews, the commitment decision by senior area chairs and program chairs, Findings versus main-conference outcomes, ethics review escalation, and resubmission strategy across cycles.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
실행 점수 미검증
설치 방법 보기설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.
Use this to model where an ACL paper actually is and who decides what next. ACL decoupled reviewing from the conference: ARR produces the review package; the conference consumes it. Confirm current mechanics at aclrollingreview.org/reviewing, since cycle structure has changed repeatedly (most recently to 10-week cycles in 2025).
acl-author-response).| Actor | Controls | Cannot do |
|---|---|---|
| Reviewer | Review text, scores, discussion updates | Accept or reject anything |
| AC / action editor | Meta-review, review-issue handling | Bind the conference's decision |
| Author | Response, revision, where/whether to commit | Change reviews after the cycle closes |
| Venue SACs + PCs | Main/Findings/reject from the ARR package | Re-run the reviewing itself |
| Ethics committee | Ethics-based conditions or rejection | Judge technical contribution |
The same review package can be committed to exactly one venue at a time, but a rejected or withheld package can target a later conference (EMNLP, EACL, NAACL, AACL) whose commitment window accepts that cycle. Sequence deliberately: each conference publishes which ARR cycles it accepts, and reviews age — a package built on a two-cycle-old baseline set gets punished at commitment.
week 0 submission deadline (AoE)
weeks 1-2 desk checks; reviewer + AC assignment
weeks 3-5 reviewing
week 5 reviews released -> author response (a few days)
week 6 reviewer discussion; reviews may be updated
weeks 7-8 meta-review written
~week 10 package complete -> commitment window for eligible venues
Offsets drift by cycle; the January 2026 cycle ran Jan 5 → reviews by early March → ACL 2026 commitment March 14. Always re-derive from the current dates page.
[Stage] cycle-intake / under review / response / meta-review / commit-window / venue decision / ethics review
[Package strength] <meta-review thrust + score pattern>
[Commit recommendation] commit to ACL / hold for revision / target sibling venue
[Ethics exposure] <flag risk and mitigation>
[Next actor to influence] <reviewer via discussion / AC via response / venue via commitment note>
아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.
로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.
아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.